|
1
|
Lim YK, Park BS, Lee SK, Kim KR and Yang
TK: A proton beam irradiation method for a uniform dose
distribution over a sample volume. J Korean Phys Soc. 48:777–780.
2006.
|
|
2
|
Suit H and Urie M: Proton beams in
radiation therapy. J Natl Cancer Inst. 84:155–164. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nieves-Alicea R, Colburn NH, Simeone AM
and Tari AM: Programmed cell death 4 inhibits breast cancer cell
invasion by increasing tissue inhibitor of metalloproteinases-2
expression. Breast Cancer Res Treat. 114:203–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effect of selenite on invasion of HT1080 tumor cells. J Biol Chem.
276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan G, Boyle JO, Yang EK, et al:
Cyclooxygenase-2 expression is up-regulated in squamous cell
carcinoma of the head and neck. Cancer Res. 59:991–994.
1999.PubMed/NCBI
|
|
7
|
Tucker ON, Dannenberg AJ, Yang EK, et al:
Cyclooxygenase-2 expression is up-regulated in human pancreatic
cancer. Cancer Res. 59:987–990. 1999.PubMed/NCBI
|
|
8
|
Adhim Z, Matsuoka T, Bito T, et al: In
vitro and in vivo inhibitory effect of three Cox-2 inhibitors and
epithelial-to-mesenchymal transition in human bladder cancer cell
lines. Br J Cancer. 105:393–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bocca C, Bozzo F, Bassignana A and
Miglietta A: Antiproliferative effects of COX-2 inhibitor celecoxib
on human breast cancer cell lines. Mol Cell Biochem. 350:59–70.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang JH, Song KH, Jeong KC, et al:
Involvement of Cox-2 in the metastatic potential of
chemotherapy-resistant breast cancer cells. BMC Cancer. 11:3342011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kundu N and Fulton AM: Selective
cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic
disease in a murine model of breast cancer. Cancer Res.
62:2343–2346. 2002.PubMed/NCBI
|
|
12
|
Morita Y, Hata K, Nakanishi M, Nishisho T,
Yura Y and Yoneda T: Cyclooxygenase-2 promotes tumor
lymphangiogenesis and lymph node metastasis in oral squamous cell
carcinoma. Int J Oncol. 41:885–892. 2012.PubMed/NCBI
|
|
13
|
Kim S, Kim SH, Hur SM, et al: Silibinin
prevents TPA-induced MMP-9 expression by down-regulation of COX-2
in human breast cancer cells. J Ethnopharmacol. 126:252–257. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KS, Mo JY, Shon YH and Nam KS:
Inhibition of metastatic activities in human breast cancer cells
irradiated by a proton beam. J Korean Phys Soc. 59:653–656. 2011.
View Article : Google Scholar
|
|
15
|
Park SY, Kim YH, Kim Y and Lee SJ:
Aromatic-turmerone attenuates invasion and expression of MMP-9 and
COX-2 through inhibition of NF-kappaB activation in TPA-induced
breast cancer cells. J Cell Biochem. 113:3653–3662. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahra T, Smart DE, Oakley F and Mann DA:
Induction of myofibroblast MMP-9 transcription in three-dimensional
collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int
J Biochem Cell Biol. 36:353–363. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin Y, Yoon SH, Choe EY, et al:
PMA-induced up-regulation of MMP-9 is regulated by a
PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol
Med. 39:97–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee KS, Shin JS and Nam KS: Starfish
polysaccharides downregulate metastatic activity through the MAPK
signaling pathway in MCF-7 human breast cancer cells. Mol Biol Rep.
40:5959–5966. 2013. View Article : Google Scholar
|
|
19
|
Cho HJ, Kang JH, Kwak JY, et al:
Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9
gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent
mechanisms. Carcinogenesis. 28:1104–1110. 2007. View Article : Google Scholar
|
|
20
|
Garg A and Aggarwal BB: Nuclear
transcription factor-kappaB as a target for cancer drug
development. Leukemia. 16:1053–1068. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pastore S, Mascia F, Mariotti F, Dattilo
C, Mariani V and Girolomoni G: ERK1/2 regulates epidermal chemokine
expression and skin inflammation. J Immunol. 174:5047–5056. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park SK, Hwang YS, Park KK, Park HJ, Seo
JY and Chung WY: Kalopanaxsaponin A inhibits PMA-induced invasion
by reducing matrix metalloproteinase-9 via PI3K/Akt− and
PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Carcinogenesis. 30:1225–1233. 2009.
|
|
23
|
Cragg GM, Newman DJ and Weiss RB: Coral
reefs, forests, and thermal vents: the worldwide exploration of
nature for novel antitumor agents. Semin Oncol. 24:156–163.
1997.PubMed/NCBI
|
|
24
|
Jang JY, Jeon YK and Kim CW: Degradation
of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of
breast cancer cells. BMC Cancer. 10:3912010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Degner SC, Kemp MQ, Bowden GT and
Romagnolo DF: Conjugated linoleic acid attenuates cyclooxygenase-2
transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast
cancer cells. J Nutr. 136:421–427. 2006.PubMed/NCBI
|
|
26
|
Guttilla IK, Phoenix KN, Hong X, Tirnauer
JS, Claffey KP and White BA: Prolonged mammosphere culture of MCF-7
cells induces an EMT and repression of the estrogen receptor by
microRNAs. Breast Cancer Res Treat. 132:75–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheng S, Qiao M and Pardee AB: Metastasis
and AKT activation. J Cell Physiol. 218:451–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agarwal A, Das K, Lerner N, et al: The
AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene
expression in colorectal cancer by activating nuclear factor-kappa
B and beta-catenin. Oncogene. 24:1021–1031. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar R, Alam S, Chaudhari BP, et al:
Ochratoxin A-induced cell proliferation and tumor promotion in
mouse skin by activating the expression of cyclin-D1 and
cyclooxygenase-2 through nuclear factor-kappa B and activator
protein-1. Carcinogenesis. 34:647–657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shao W, Wang D and He J: The role of gene
expression profiling in early-stage non-small cell lung cancer. J
Thorac Dis. 2:89–99. 2010.PubMed/NCBI
|
|
31
|
Altundag K and Ibrahim NK: Aromatase
inhibitors in breast cancer: an overview. Oncologist. 11:553–562.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kupferman ME, Fini ME, Muller WJ, Weber R,
Cheng Y and Muschel RJ: Matrix metalloproteinase 9 promoter
activity is induced coincident with invasion during tumor
progression. Am J Pathol. 157:1777–1783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang C and Werb Z: The many faces of
metalloproteases: cell growth, invasion, angiogenesis and
metastasis. Trends Cell Biol. 11:S37–S43. 2001. View Article : Google Scholar : PubMed/NCBI
|
